{
  "docId": "019de076-48c2-7315-bf77-72d2721572a4",
  "docSlug": "9ba2b11c98152a86fe4ad3555ff50f91",
  "documentTitle": "Immatics | Investor Presentation Deck | 75 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 39,
  "pageCount": 75,
  "prevPage": 38,
  "nextPage": 40,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 15,
  "notes": "The slide uses a four-column layout to summarize the therapeutic profile of the drug candidate.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-48c2-7315-bf77-72d2721572a4/39",
  "deckHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4",
  "deckJsonHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4.json",
  "deckAnchorHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4#slide-39",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.22,
        "x": 0.04,
        "y": 0.21
      },
      "kind": "list",
      "text": "TARGET: HLA-A*02-presented peptide derived from COL6A3 exon 6; 100-700 copies/cell; validated by XPRESIDENT®",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "127fda34-b32c-459f-ad41-bcb2d4d6a671",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.22,
        "x": 0.27,
        "y": 0.21
      },
      "kind": "list",
      "text": "TCR: High-affinity, specific TCR targeting COL6A3 exon 6; CD8-independent; ~0.01ng/ml avidity; XCEPTOR® platform",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42a41912-0e7a-40b3-813a-6e5097b85976",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.22,
        "x": 0.75,
        "y": 0.21
      },
      "kind": "list",
      "text": "PATIENT POPULATION: Pancreatic (76%), Breast (77%), Stomach (67%), Sarcoma (63%), Colorectal (60%), Esophageal (60%), NSCLC (55-57%), HNSCC (56%), Uterine (50%), Mesothelioma (44%), Cholangio (36%), Melanoma (35%), Bladder (34%), Ovarian (31%)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b244ce19-32ba-4f84-8b0b-95848c1fa716",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.22,
        "x": 0.51,
        "y": 0.21
      },
      "kind": "list",
      "text": "PRECLINICAL DATA: CD8-independent; engages CD8/CD4 T cells; in vitro anti-tumor activity; in vivo tumor eradication",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b63d4c4d-4015-4e49-a43e-cb93c2c2305b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.15,
        "y": 0.85
      },
      "kind": "paragraph",
      "text": "IMA204 provides a promising therapeutic opportunity for a broad patient population as monotherapy or in combination with TCR-T cells directed against tumor targets",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1917ab6-bda6-4009-a3d6-ddc7bbf436f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.04,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1 Target density: peptide copy number... 2 Functional avidity: EC50... 3 Solid cancer indications with 20% or more target expression...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8987d6d4-dccf-4f3c-bc26-36ee32a1f506",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "ACTengine® IMA204 First-in-Class TCR-T Targeting Tumor Stroma",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "325a9e30-5ce8-4b97-ab75-ca0c82244748",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "title",
      "text": "Key Features",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "006fd471-a996-4b56-9d6a-3cc703dd9ca1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}